PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Timolol - Glaucoma / ocular hypertension
PAD Profile : Timolol - Glaucoma / ocular hypertension
Keywords :
Intra-ocular pressure
Brand Names Include :
Tiopex, Timoptol-LA, Eysano, Timoptol,
Traffic Light Status
Status 1 of 3.
Status :
Blue
Important
Formulations :
- Eye drops
Important Information :
0.25% and 0.5% eye drops. Prescribe generically. Initiation by specialist team before transfer of prescribing to primary care.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Status 2 of 3.
Status :
Blue
Important
Formulations :
- Eye gel
Important Information :
0.25% and 0.5% gel-forming solution (Timoptol-LA)
Initiation by specialist team before transfer of prescribing to primary care.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Status 3 of 3.
Status :
Blue
Important
Formulations :
- Eye drops (preservative free, unit dose)
Important Information :
0.1% (1mg/g) preservative free eye gel. Once daily use.
Initiation by specialist team before transfer of prescribing to primary care.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Guidelines
No guidelines returned.
Other Drugs
- Latanoprost
- Bimatoprost
- Dorzolamide and timolol
- Brinzolamide
- Brimonidine tartrate
- Dorzolamide
- Latanoprost and timolol
- Acetazolamide
- Timolol and bimatoprost
- Timolol and brimonidine
- Brinzolamide/brimonidine
- Brinzolamide and timolol
- Tafluprost
- Travoprost
- Timolol and travoprost
- Pilocarpine hydrochloride
- Betaxolol
- Levobunolol hydrochloride
- Apraclonidine
Other Indications
No indications returned.
Additional Documents
Type
Document
Review Date
Committee Recommendations
Date
Committee Name
Narrative
02 October 2024
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.
02 November 2016
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
The PCN recommends the prescribing of timolol maleate 1mg/g preservative free eye gel (Tiopex) as an alternative treatment option*, for the reduction of elevated intraocular pressure in patients with ocular hypertension or glaucoma where a preservative free preparation is indicated. Tiopex will be considered Blue (no information sheet) on the traffic light system. *Once daily formulation which may be a more cost effective treatment option for some patients as an alternative to timolol preservative free single dose vials.
Associated BNF Codes
11. Eye
11.06.00. Treatment of glaucoma